Chemical formula: C₂₅H₃₄F₂O₅ Molecular mass: 452.531 g/mol PubChem compound: 9868491
Tafluprost is indicated for:
Population group: only adults (18 years old or older)
Reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.
As monotherapy in patients:
As adjunctive therapy to beta-blockers.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Tafluprost is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
